scholarly journals Fosfomycin, a therapeutic option for infections produced by multiple drug-resistant Enterobacteriaceae

2016 ◽  
Vol 7 (1) ◽  
Author(s):  
Fatemeh Yeganeh Sefidan ◽  
Robab Azargun ◽  
Reza Ghotaslou

Due to the increasing prevalence of infections caused by resistant bacteria and especially multiple drug resistance <em>Enterobacteriaceae</em>, availability of alternative effective antibiotics is restricted. The goal of this study was to investigate the susceptibility profile of multiple drug resistance and extensively drug resistance <em>Enterobacteriaceae</em> isolated from various clinical samples to fosfomycin. A total of 303 non-duplicate <em>Enterobacteriaceae</em> isolates were collected. Identification and susceptibility testing were done according to standard microbiological procedures and the Kirby-Bauer test, respectively. Of all isolates, 272 (89.8%) and 26 (8.6%) were detected as multiple drug resistance and extensively drug resistance strains, respectively. The most effective antibiotic (98%) was fosfomycin, when compared with other antibiotics against multiple drug resistance and extensively drug resistance <em>Enterobacteriaceae</em> isolates. In this study, we find high levels of resistance to commonly used antibiotics. However, fosfomycin can be a good option for treating multiple drug resistance <em>Enterobacteriaceae</em>.

2021 ◽  
Vol 9 (3) ◽  
pp. 5-10
Author(s):  
N.V. Kuznetsov ◽  
A.S. Lesonen ◽  
U.M. Markelov ◽  
E.D. Mikhailova

The article presents the results of predicting the dynamics of the spread of new cases of tuberculosis (TB) with multiple drug resistance (MDR) in the Republic of Karelia, as well as the costs of treating patients with tuberculosis, considering the different effectiveness of treatment. It has been demonstrated that while enhancing efficiency of treatment, due to the rapid determination of drug resistance by the method of polymerase chain reaction and a decrease in treatment gaps (using food kits), the effectiveness of treatment is significantly increased and the prevalence of MDR-TB decreases, which leads to significant budget savings.


2019 ◽  
Vol 20 (9) ◽  
pp. 720-741 ◽  
Author(s):  
Ayse Basak Engin ◽  
Atilla Engin

Background: The main drawbacks for using conventional antimicrobial agents are the development of multiple drug resistance due to the use of high concentrations of antibiotics for extended periods. This vicious cycle often generates complications of persistent infections, and intolerable antibiotic toxicity. The problem is that while all new discovered antimicrobials are effective and promising, they remain as only short-term solutions to the overall challenge of drug-resistant bacteria. Objective: Recently, nanoantibiotics (nAbts) have been of tremendous interest in overcoming the drug resistance developed by several pathogenic microorganisms against most of the commonly used antibiotics. Compared with free antibiotic at the same concentration, drug delivered via a nanoparticle carrier has a much more prominent inhibitory effect on bacterial growth, and drug toxicity, along with prolonged drug release. Additionally, multiple drugs or antimicrobials can be packaged within the same smart polymer which can be designed with stimuli-responsive linkers. These stimuli-responsive nAbts open up the possibility of creating multipurpose and targeted antimicrobials. Biofilm formation still remains the leading cause of conventional antibiotic treatment failure. In contrast to conventional antibiotics nAbts easily penetrate into the biofilm, and selectively target biofilm matrix constituents through the introduction of bacteria specific ligands. In this context, various nanoparticles can be stabilized and functionalized with conventional antibiotics. These composites have a largely enhanced bactericidal efficiency compared to the free antibiotic. Conclusion: Nanoparticle-based carriers deliver antibiotics with better biofilm penetration and lower toxicity, thus combating bacterial resistance. However, the successful adaptation of nanoformulations to clinical practice involves a detailed assessment of their safety profiles and potential immunotoxicity.


2012 ◽  
Vol 78 (17) ◽  
pp. 6137-6142 ◽  
Author(s):  
Gabriel G. Perron ◽  
Sergey Kryazhimskiy ◽  
Daniel P. Rice ◽  
Angus Buckling

ABSTRACTThe evolution of drug resistance among pathogenic bacteria has led public health workers to rely increasingly on multidrug therapy to treat infections. Here, we compare the efficacy of combination therapy (i.e., using two antibiotics simultaneously) and sequential therapy (i.e., switching two antibiotics) in minimizing the evolution of multidrug resistance. Usingin vitroexperiments, we show that the sequential use of two antibiotics againstPseudomonas aeruginosacan slow down the evolution of multiple-drug resistance when the two antibiotics are used in a specific order. A simple population dynamics model reveals that using an antibiotic associated with high costs of resistance first minimizes the chance of multidrug resistance evolution during sequential therapy under limited mutation supply rate. As well as presenting a novel approach to multidrug therapy, this work shows that costs of resistance not only influences the persistence of antibiotic-resistant bacteria but also plays an important role in the emergence of resistance.


2020 ◽  
Vol 17 (3) ◽  
pp. 348-356
Author(s):  
Bhoj R. Singh ◽  
Dharmendra K. Sinha ◽  
Vinodh K. OR ◽  
Prasanna Vadhana ◽  
Monika Bhardwaj ◽  
...  

Background and Objectives: Multiple-Drug-Resistance (MDR) among bacteria is an imminent problem and alternative therapies are seen as a future abode. Agarwood Oil (AO) is described to possess antimicrobial activity besides many other medicinal utilities. This paper discusses the antimicrobial activity of AO on MDR and non-MDR strains of microbes of 69 genera isolated from clinical and non-clinical samples. Methods and Results: In this study sensitivity of microbes was determined for conventional antimicrobials and AO using disc diffusion assay followed by determination of minimum inhibitory concentration (MIC) using agar well dilution assay. A total of 18.5% (522) strains were found sensitive to AO. Carbapenem resistant bacterial strains were more often (p, ≤0.01) resistant to antibiotics with 4.2 times more odds (99% CI, 2.99-5.90) of being MDR than carbapenem sensitive strains but no difference in their AO sensitivity was observed. However, MDR strains were more often (p, <0.001) resistant to AO than non-MDR strains. Bacteria isolated from dogs were more often sensitive to AO than those from buffaloes, human, horse, and cattle. On the other hand, bacteria from pigs were more often (p, ≤0.05) resistant to AO than bacteria from human, cattle, buffaloes, dogs, wild carnivores and birds. Oxidase positive Gram positive bacteria had 4.29 (95% CI, 2.94-6.27) times more odds to be AO sensitive than oxidase negative Gram negative bacteria. Bacillus species strains were the most sensitive bacteria to AO followed by strains of Streptococcus and Staphylococcus. The MIC of AO for different bacteria ranged from 0.01 mg/mL to > 2.56 mg/mL. Conclusion: The study concluded that MDR and AO resistance had a similar trend and AO may not be seen as a good antimicrobial agent against MDR strains.


1970 ◽  
Vol 8 (1) ◽  
pp. 40-44 ◽  
Author(s):  
Dr Sharma ◽  
B Pradhan ◽  
SK Mishra

Background: Healthcare liquid wastes are the reservoirs of harmful infectious agents such as the pathogens and multiple drug resistant microorganisms. Potential infectious risks include the spread of infectious diseases and microbial resistance from health-care establishments into the environment and thereby posing risks of getting infections and antibiotic resistance in the communities. Objectives: The objectives of this study were to assess the bacterial load of healthcare liquid waste generated in central hospitals and to explore the antimicrobial resistance pattern of these bacterial isolates. Materials and methods: A descriptive study was carried out in 10 conveniently selected central hospitals of Nepal during the period of May to December 2008. Effluent specimens from each hospital were subjected to total viable count studies by spread plate method in nutrient agar plate and incubated for 24 hours at 37°C using standard laboratory protocol. Similarly, all the specimens were cultured in Mac Conkey Agar media supplemented with 30 μg/ml of Chloramphenicol and 20 μg/ml of Gentamycin for the enumeration of multiple drug resistant (MDR) bacteria, which were further subjected to in-vitro antibiotic susceptibility test by modified Kirby Bauer disc diffusion technique for resistance patterns. Results: Total viable counts of hospital effluents significantly exceeded the standard heterotrophic plate count (p=0.000). Similarly, the numbers of multiple drug resistant bacteria were alarmingly high in three (more than 30% in 2 and 50% in 1) hospitals of this study. Drug resistant hospital effluent isolates showed simultaneous resistance for most of the antibiotics including Penicillin, Cephalosporin, Cotrimoxazole, Gentamycin and Quinolones. Conclusion: Healthcare liquid wastes were laden with MDR bacteria and seemed to pose a huge public health threat in the transfer of such resistance to the bacterial pathogens causing community acquired infections, thereby limiting our antibiotic pool. Key words: Healthcare liquid waste management; viable count; multiple drug resistance; hospitals; Nepal DOI: 10.3126/kumj.v8i1.3220 Kathmandu University Medical Journal (2010), Vol. 8, No. 1, Issue 29, 40-44


2007 ◽  
Vol 51 (12) ◽  
pp. 4515-4517 ◽  
Author(s):  
Ruiru Shi ◽  
Jianyuan Zhang ◽  
Koji Otomo ◽  
Guolong Zhang ◽  
Isamu Sugawara

ABSTRACT Seventy-four Mycobacterium tuberculosis clinical isolates from China were subjected to drug susceptibility testing using ethambutol, isoniazid, rifampin, and ofloxacin. The results revealed that the presence of embB mutations did not correlate with ethambutol resistance but was associated with multiple-drug resistance, especially resistance to both ethambutol and rifampin.


Author(s):  
Oludare Temitope Osuntokun ◽  
Owolabi Mutolib Bankole ◽  
Thonda Oluwakemi Abike ◽  
Omoyungbo Emmanuel Joy ◽  
Ajadi Fatima Adenike

The rapid emergence of resistant bacteria is occurring worldwide, endangering the efficacy of antibiotics, therefore, there is a need for a systematic approach to the menace of resistant bacteria. Green synthesized nanoparticle (NPs) of medicinal plant based as become an alternative way out to total eradication of resistant microorganisms, Therefore, the search for new, effective bactericidal agents is imminent significantly, for combating drug resistance microorganism. This research work aims to isolate, identify and characterize endophytic bacteria from five non-leguminous plants, namely Carica papaya, Helianthus annuus, Talinum fruticosum, Phoenix dactylifera, and Solanum lycopersicum. The surface of the plants were sterilized, Isolation, characterization and identification using biochemical characterization of the endophytic bacteria were examined according to Bergey’s manual of Systemic Bacteriology. The sulfur/medicinal plant mediated Nanoparticle with and without Ocimum gratissimum were tested against the endophytic bacteria and selected clinical isolates, for their antimicrobial susceptibility test as described Kirby-Bauer Disc diffusion method. SNP1 was prepared from sodium thiosulfate penthahydrate, citric acid, with fresh leaves of O. gratissimum and characterized by using Shimadzu UV-VIS-NIR Spectrophotometer UV-3100 with a MPCF-3100 sample compartment while SNP2 was prepared using the same method but without O. gratissimum. The endophyte showed resistant to cephalosporin antibiotics family and SNP2, while all the endophytic bacteria were susceptible to ciprofloxacin (100%), pefloxacin (100%). Streptococcus infectinalis and Cellumonas flavigena showed high susceptibility to sulfur/ plant nanoparticle mediated with Ocimum gratissimum extract (SNP1). The study showed that sulfur/medicinal plant mediated nanoparticle can be a promising antimicrobial agent against a wide range of pathogenic and multiple drug resistance bacteria including both clinical isolates, its uses and practice should be encouraged especially against multiple drug resistance bacteria.


Sign in / Sign up

Export Citation Format

Share Document